Oscar Health, Inc. (NYSE:OSCR) Receives $24.00 Consensus Target Price from Analysts

Oscar Health, Inc. (NYSE:OSCR) has received an average recommendation of “Hold” from the eleven research firms that are covering the company, MarketBeat reports. Seven analysts have rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company. The average twelve-month price objective among analysts that have issued ratings on the stock in the last year is $25.4444.

Several research analysts have weighed in on the stock. Weiss Ratings upgraded shares of Oscar Health from a “sell (d+)” rating to a “hold (c+)” rating in a research note on Tuesday. Wall Street Zen raised Oscar Health from a “buy” rating to a “strong-buy” rating in a research report on Sunday, June 14th. Zacks Research upgraded Oscar Health from a “hold” rating to a “strong-buy” rating in a research note on Monday, July 6th. UBS Group upped their target price on Oscar Health from $20.00 to $26.00 and gave the stock a “neutral” rating in a research report on Friday, August 7th. Finally, Jefferies Financial Group raised Oscar Health from an “underperform” rating to a “hold” rating and raised their price target for the stock from $10.00 to $16.00 in a research note on Monday, April 20th.

Oscar Health Price Performance

NYSE OSCR opened at $29.79 on Monday. The stock’s 50-day moving average price is $29.35 and its two-hundred day moving average price is $20.67. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 0.26. The company has a market cap of $8.98 billion, a PE ratio of 21.28, a PEG ratio of 0.58 and a beta of 2.36. Oscar Health has a 1 year low of $10.69 and a 1 year high of $33.10.

Oscar Health (NYSE:OSCR) last announced its earnings results on Thursday, August 6th. The company reported $1.10 EPS for the quarter, topping the consensus estimate of $0.40 by $0.70. The company had revenue of $4.88 billion during the quarter, compared to analysts’ expectations of $4.73 billion. Oscar Health had a net margin of 3.60% and a return on equity of 44.96%. The business’s revenue for the quarter was up 70.4% on a year-over-year basis. During the same period last year, the company posted ($0.89) earnings per share. On average, analysts predict that Oscar Health will post 1.54 EPS for the current year.

Insiders Place Their Bets

In related news, insider Janet Liang sold 12,475 shares of the stock in a transaction that occurred on Tuesday, June 2nd. The stock was sold at an average price of $21.94, for a total value of $273,701.50. Following the transaction, the insider owned 259,057 shares in the company, valued at approximately $5,683,710.58. This represents a 4.59% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Richard Scott Blackley sold 31,683 shares of the business’s stock in a transaction dated Tuesday, June 2nd. The stock was sold at an average price of $21.94, for a total value of $695,125.02. Following the completion of the sale, the chief financial officer directly owned 1,074,977 shares of the company’s stock, valued at $23,584,995.38. This represents a 2.86% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 3,562,466 shares of company stock worth $102,829,815 in the last quarter. Corporate insiders own 22.64% of the company’s stock.

Hedge Funds Weigh In On Oscar Health

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Jones Financial Companies Lllp lifted its position in shares of Oscar Health by 7,473.3% during the 1st quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock worth $30,000 after buying an additional 2,242 shares during the period. Strs Ohio acquired a new stake in Oscar Health in the 1st quarter valued at about $30,000. Fifth Third Bancorp lifted its position in shares of Oscar Health by 148.7% during the fourth quarter. Fifth Third Bancorp now owns 2,363 shares of the company’s stock worth $34,000 after purchasing an additional 1,413 shares in the last quarter. CoreCap Advisors LLC grew its stake in shares of Oscar Health by 526.3% during the second quarter. CoreCap Advisors LLC now owns 1,190 shares of the company’s stock valued at $34,000 after purchasing an additional 1,000 shares during the last quarter. Finally, Quarry LP grew its stake in shares of Oscar Health by 439.8% during the third quarter. Quarry LP now owns 1,803 shares of the company’s stock valued at $34,000 after purchasing an additional 1,469 shares during the last quarter. Institutional investors own 75.70% of the company’s stock.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.